Forsteo

Forsteo (Teriparatide) is a subcutaneous medication used to treat osteoporosis. It helps improve bone density and reduce fracture risk. Learn more about its uses and effects.

Forsteo, containing the active ingredient Teriparatide, is primarily used for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture. It works by stimulating bone formation, which can help increase bone mass and strength. People often ask, 'What is Forsteo used for?' and the answer is that it is designed to reduce the risk of fractures in individuals with severe osteoporosis who are at high risk for bone breaks.

Common effects of Forsteo may include injection site reactions such as redness, swelling, or pain. Some users might experience dizziness, nausea, or leg cramps. These effects are generally mild and temporary. It's important to monitor any persistent or severe reactions and consult a healthcare provider if necessary.

Forsteo should be used with caution in individuals with a history of bone cancer or metabolic bone diseases. It is not recommended for use in patients with Paget's disease of bone or hypercalcemia. Always follow the advice of a healthcare professional regarding the use of this medication.

Forsteo may interact with other medications, including those that affect calcium levels or bone metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Forsteo.